MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
and redemptions of...
$130,983K
Net cash provided by
(used in) investing...
$35,547K
Canceled cashflow
$95,436K
Net (decrease)
increase in cash, cash...
-$37,709K
Canceled cashflow
$35,547K
something is missing
$118,081K
Interest expense accrued
on liabilities...
$10,493K
Increase in deferred
revenue
$5,512K
Increase in accounts
payable
$5,421K
(increase) decrease in
prepaid expenses and...
-$4,588K
Inventory reserves and
write-offs
$4,335K
Share-based compensation
net of amounts...
$3,835K
Foreign exchange
differences
-$3,219K
(decrease) increase in
accrued expenses and...
$2,710K
Increase (decrease) in
operating lease liability
$2,593K
Depreciation on property and
equipment
$2,079K
Amortization of right-of-use
assets
$825K
Amortization of intangible
assets
$459K
Deferred income tax
-$13K
Purchases of marketable
securities...
$82,939K
Acquisition of intangibles
assets
$8,089K
Acquisition of property and
equipment
$4,408K
Net cash used in
operating activities
-$67,899K
Canceled cashflow
$164,163K
Effect of exchange rate
changes on cash, cash...
-$3,583K
Net cash (used in)
provided by financing...
-$1,774K
Interest income
$15,753K
Foreign exchange
(losses) gains, net
$1,769K
Other income, net
$349K
Net loss
-$197,196K
Canceled cashflow
$17,871K
Increase in prepaid
expenses and other...
$18,573K
Increase in inventories,
net
$8,602K
Increase in accounts
receivable, net
$6,001K
Accretion of
available-for-sale securities
-$1,690K
Payments of revenue share
$1,774K
Total
revenue-Product
$51,049K
Total
revenue-License
$50K
Loss from operations
-$198,078K
Canceled cashflow
$51,099K
Interest expense, net
$13,834K
Income tax expenses
$3,155K
Total operating
expenses
$249,177K
Cost of sales
$71,039K
Support functions
$60,908K
Commercial and medical
affairs
$52,488K
Research and clinical
development
$45,231K
Product delivery
$15,170K
Other segment
expenses, net
$4,341K
Back
Back
Cash Flow
source: myfinsight.com
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)